Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Exchange Rate Effect (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Exchange Rate Effect for 3 consecutive years, with -$1.5 million as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 88.85% to -$1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.7 million through Dec 2025, up 1660.83% year-over-year, with the annual reading at $26.7 million for FY2025, 1660.83% up from the prior year.
  • Exchange Rate Effect hit -$1.5 million in Q4 2025 for Immunocore Holdings, down from $7.8 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $12.3 million in Q3 2024 to a low of -$13.0 million in Q4 2024.
  • Historically, Exchange Rate Effect has averaged $2.8 million across 3 years, with a median of $2.8 million in 2023.
  • Biggest five-year swings in Exchange Rate Effect: crashed 220.86% in 2024 and later surged 7564.15% in 2025.
  • Year by year, Exchange Rate Effect stood at $10.8 million in 2023, then plummeted by 220.86% to -$13.0 million in 2024, then soared by 88.85% to -$1.5 million in 2025.
  • Business Quant data shows Exchange Rate Effect for IMCR at -$1.5 million in Q4 2025, $7.8 million in Q3 2025, and $11.9 million in Q2 2025.